Tuberculosis Therapy
Gatifloxacin-containing regimen offers potential shorter treatment for TB
Published in TB and Outbreaks Week, February 7th, 2006
The Phase II trial results of a gatifloxacin-containing regimen are demonstrating good potential. The regimen is significantly more potent than the currently recommended 6-month regimen of isoniazid, rifampicin, pyrazinamide, and ethambutol, and suggests that when gatifloxacin is used instead of ethambutol, the standard 6-month regimen may be shortened to 4 months.
"We are working to bring...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Clostridium Outbreaks
C. difficile-associated diarrhea outbreak resulted in high morbidity and mortality - Coxsackievirus Outbreak
Hemorrhagic conjunctivitis epidemic by coxsackievirus A24 variants is reported in Korea - Drug Resistance
Community-acquired MRSA is an emerging problem in athletes - Infectious Diseases
Previous smallpox vaccination not associated with monkeypox disease severity - Meningococcal Meningitis
W135 meningococcal meningitis rapidly evolving in Ghana - Allergy & Immunology
Cytomegalovirus infection inhibits immune responses generated against P. carinii - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
